Editorial
Published on 14 Oct 2022
Editorial: Influences in the progression of renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1059615
- 1,140 views
- 3 citations
Type at least 3 characters
1,652 articles
Review
Published on 14 Oct 2022
Cellular milieu in clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.943583
- 4,791 views
- 11 citations
Review
Published on 13 Oct 2022
A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1000888
- 6,633 views
- 8 citations
Original Research
Published on 13 Oct 2022
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.990367
- 3,998 views
- 15 citations
Original Research
Published on 12 Oct 2022
Prognosis of clear cell renal cell carcinoma patients stratified by age: A research relied on SEER database
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.975779
- 5,098 views
- 9 citations
Systematic Review
Published on 12 Oct 2022
Whole-gland high-intensity focused ultrasound ablation and transurethral resection of the prostate in the patients with prostate cancer: A systematic review and meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.988490
- 3,401 views
- 5 citations
Original Research
Published on 12 Oct 2022
A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.964838
- 1,962 views
Original Research
Published on 11 Oct 2022
Increased urinary B2-microglobulin is associated with poor prognosis of upper tract urothelial carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1008763
- 2,239 views
- 3 citations
Original Research
Published on 10 Oct 2022
An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1019057
- 1,843 views
- 3 citations
Original Research
Published on 10 Oct 2022
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1018285
- 4,142 views
- 10 citations
Original Research
Published on 10 Oct 2022
Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.994703
- 3,730 views
- 13 citations
Original Research
Published on 07 Oct 2022
Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.982267
- 2,771 views
- 3 citations
Original Research
Published on 06 Oct 2022
Ultrasound-guided posterior quadratus lumborum block can reduce postoperative opioid consumption and promote rapid recovery in patients undergoing sutureless laparoscopic partial nephrectomy: A triple-blind, randomized, controlled study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.969452
- 2,322 views
- 4 citations
Case Report
Published on 06 Oct 2022
Primary urachal signet ring cell carcinoma: A case report
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1034245
- 1,881 views
- 2 citations
Original Research
Published on 06 Oct 2022
Novel serum proteomic biomarkers for early diagnosis and aggressive grade identification of prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1004015
- 3,305 views
- 10 citations
Original Research
Published on 06 Oct 2022
Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1017425
- 3,471 views
- 9 citations